Trial intelligence / Profile preview

Bioequivalence study of choline fenofibrate 135 mg in healthy Thai volunteers under fasting conditions

TCTR20180827002Completed

Sponsor
All Research
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of fenofibric acid (2 arms), sponsored by All Research. Primary endpoints: Cmax at 72 hours, AUC0-t and 1 more. Started Oct 2018; status: completed.

02

Drugs

fenofibric acid

Beyond the preview

Go deeper on TCTR20180827002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180827002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call